Effects of amifostine on the proliferation and differentiation of megakaryocytic progenitor cells

European Journal of Pharmacology

Volumn 437, Issue 1-2, 2002, Pages 19-25

  Kashiwakura, Ikuo ^a   Murakami, Miho ^a   Inanami, Osamu ^b   Hayase, Yukitoshi ^a   Takahashi, Tsuneo A ^c   Kuwabara, Mikinori ^b   Takagi, Yoshinari ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Amifostine; CD34 antigen; Colony forming units assay; Hematopoietic stem cell; Thrombopoietin; X ray

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; CD34 ANTIGEN; RECOMBINANT THROMBOPOIETIN;

ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PLACENTA; PLOIDY; PRIORITY JOURNAL; RADIATION PROTECTION; STEM CELL; THROMBOCYTOPOIESIS; UMBILICAL CORD BLOOD; X IRRADIATION;

AMIFOSTINE; ANTIGENS, CD; ANTIGENS, CD34; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CLONE CELLS; CULTURE MEDIA; DNA; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; PLOIDIES; RADIATION-PROTECTIVE AGENTS; THROMBOPOIETIN;

EID: 0037083853     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01270-0     Document Type: Article

References (22)

1. Gene expression and the thiol redox state
2. Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer
3. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients
4. Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy
5. + progenitor cells from bone marrow and G-CSF-mobilized peripheral blood
6. Bone marrow stem cell protection from chemotherapy by low-molecular-weight compounds
7. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin
8. Effects of -phenyl N-tert-butylnitrone, a spin trap reagent, on the proliferation of murine hematopoietic progenitor cells in vitro
9. Radiation sensitivity of megakaryocyte colony-forming cells in human placental/umbilical cord blood
10. Chemoprotection in anticancer therapy: The emerging role of amifostine (WR-2721)
11. Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity
12. Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors
13. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa
14. The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway
15. Ex vivo expanded unselected peripheral blood: Progenitor cells reduce post-transplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer
16. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: Implications for mechanisms of radioprotection
17. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF- /Rel transcription factors
18. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors
19. Radioprotection of cells in culture by WR-2721 and derivatives: Form of the drug responsible for protection
20. Amifostine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector
21. WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: A molecular approach